[Treatment of angina pectoris with special reference to beta-blockers].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D000925:Anticoagulants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004070:Digitalis; D004359:Drug Therapy, Combination; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000627:therapeutic use; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011412:Propanolamines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D009566:Nitrates; D011412:Propanolamines; D010417:Pentaerythritol Tetranitrate; C011550:talinolol; D011433:Propranolol; D014700:Verapamil; D005996:Nitroglycerin; D009543:Nifedipine
Zur Therapie der Angina pectoris unter besonderer Berücksichtigung der Betablocker.